Loading clinical trials...
Loading clinical trials...
This study intends to apply for the establishment of research beds, establish a Chinese PVRL research cohort, and carry out a to achieve the following research objectives: The goal of this prospective observational study is to construct the diagnosis and treatment system for primary vitreoretinal lymphoma(PVRL). The study is to achieve the following research objectives: 1. To establish a comprehensive diagnostic criteria for PVRL with high diagnostic efficiency and strengthen the PVRL diagnostic system; 2. To establish a standardized treatment pathway for PVRL and evaluate the efficacy and safety of treatment; 3. To screen the prognosis evaluation indicators, and to establish the follow-up process and prognosis evaluation system of PVRL; 4. To explore the pathogenesis of PVRL, specific tumor markers and drug therapeutic targets.
Age
18 - 75 years
Sex
ALL
Healthy Volunteers
Yes
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Start Date
October 1, 2022
Primary Completion Date
December 1, 2024
Completion Date
September 1, 2025
Last Updated
July 18, 2023
100
ESTIMATED participants
Intravitreal injection of methotrexate
DRUG
Lead Sponsor
Peking Union Medical College Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions